I 
110TH CONGRESS 
2D SESSION 
H. R. 6089 
To amend title IV of the Public Health Service Act to provide for the 
establishment of pediatric research consortia. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 20, 2008 
Ms. DEGETTE (for herself, Mr. KING of New York, Mrs. CAPPS, Mr. 
CAPUANO, Mr. EMANUEL, Mrs. EMERSON, Mr. GENE GREEN of Texas, 
Mr. JACKSON of Illinois, Mr. KIRK, Mr. TIM MURPHY of Pennsylvania, 
Ms. PRYCE of Ohio, and Mr. VAN HOLLEN) introduced the following bill; 
which was referred to the Committee on Energy and Commerce 
A BILL 
To amend title IV of the Public Health Service Act to 
provide for the establishment of pediatric research consortia. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Pediatric Research 
Consortia Establishment Act’’. 
SEC. 2. NATIONAL PEDIATRIC RESEARCH CONSORTIA. 
Subpart 7 of part C of title IV of the Public Health 
Service Act (42 U.S.C. 285g et seq.) is amended by adding 
at the end the following: 
VerDate Aug 31 2005 
21:40 May 21, 2008
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6089.IH
H6089
hsrobinson on PROD1PC76 with BILLS
‘‘SEC. 452H. NATIONAL PEDIATRIC RESEARCH CONSORTIA. 
‘‘(a) IN GENERAL.—The Director of the National In-
stitutes of Health, acting through the Director of the Na-
tional Institute of Child Health and Human Development 
and in collaboration with all other Institutes of the Na-
tional Institutes of Health that support pediatric research, 
shall award grants, contracts, or cooperative agreements 
to public or nonprofit private entities to pay all or part 
of the cost of planning, establishing, and providing basic 
operating support for up to 20 national pediatric research 
consortia. 
‘‘(b) RESEARCH.—Each consortium establish under 
subsection (a) shall supplement, but not replace, the estab-
lishment of a comprehensive pediatric research portfolio. 
Such consortium shall conduct basic, clinical, behavioral, 
social, and translational research, as well as training and 
demonstration of advanced diagnostic and treatment 
methods relating to pediatrics. 
‘‘(c) COORDINATION OF CONSORTIA REPORTS.—The 
Director of NIH shall— 
‘‘(1) as appropriate, provide for the coordina-
tion of information among consortia under sub-
section (a) and ensure regular communication be-
tween such consortia; and 
VerDate Aug 31 2005 
21:40 May 21, 2008
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6089.IH
H6089
hsrobinson on PROD1PC76 with BILLS
‘‘(2) require the periodic preparation of reports 
on the activities of the consortia and the submission 
of the reports to the Director. 
‘‘(d) ORGANIZATION OF CONSORTIUM.—Each consor-
tium established under subsection (a) shall be formed from 
a collaboration of cooperating institutions with a lead in-
stitution, meeting such requirements as may be prescribed 
by the Director of NIH, including participation in a net-
work of such consortium. 
‘‘(e) LIMITATION.—Payments under subsection (a) 
shall not exceed $2,500,000 per year for each consortium 
in the first 5 year cycle. 
‘‘(f) DURATION OF SUPPORT.—Support for a consor-
tium established under subsection (a) may be provided 
under this section for a period of 5 years and may be ex-
tended for additional periods of 5 years each, with en-
hanced funding opportunities based on a review of the op-
erations by an appropriate scientific review group estab-
lished by the Director.’’. 
Æ 
VerDate Aug 31 2005 
21:40 May 21, 2008
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6089.IH
H6089
hsrobinson on PROD1PC76 with BILLS